Patent · US Expired

Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders

US7279593B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignee

Karo Bio AB · SE

Inventors

Johan Malm · Älta, SE
Peter Brandt · Uppsala, SE
Karin Edvinsson · Stockholm, SE
Konrad Koehler · Huddinge, SE
Andrei Sanin · Kalmar, SE
Sandra Gordon · Mariefred, SE

Key dates

Filing date	Aug 13, 2002
Grant date	Oct 9, 2007
Priority date	—
Expiry date	Jul 8, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D241/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to novel compounds which are thyroid receptor ligands, preferably antagonists, and to methods for using such compounds in the treatment of cardiac and metabolic disorders, such as cardiac arrhythmias, thyrotoxicosis, subclinical hyperthyrodism and liver diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.